aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Gallant Pet, founded in 2018 by Aaron Hirschhorn and headquartered in San Diego, California, is dedicated to advancing veterinary care through innovative stem cell therapies. The company focuses on retrieving and preserving stem and regenerative cells from pets, particularly dogs, to treat wounds and other veterinary diseases. Gallant Pet aims to provide pet owners with cutting-edge treatment options that leverage the latest advancements in stem cell science.
Notable affiliated individuals include founder Aaron Hirschhorn, who has been instrumental in steering the company's mission. Gallant Pet has made significant strides in veterinary medicine, with several clinical trials in progress and a robust pipeline of upcoming trials. The company’s efforts have positioned it as a leader in the field of veterinary stem cell therapy, making a substantial impact on pet healthcare by offering advanced treatment solutions that improve the quality of life for pets.
Operating Status
Active
Ownership Type(s)
Venture Capital
Main Product(s)
Stem Cell Therapy
Technology
Biotech
Tags
Healthtech
Model Types
Professional Services, Platform
Revenue Type(s)
Recurring
Customer Type(s)
Consumers
Geographic Exposure
United States
When was Gallant Pet founded?
Gallant Pet was founded in 2018.
Where is Gallant Pet's headquarters located?
Gallant Pet's headquarters is located in Los Angeles, CA, US.
How many employees does Gallant Pet have?
Gallant Pet has 30 employees as of Feb 5, 2024.
How much has Gallant Pet raised to-date?
As of July 05, 2023, Gallant Pet has raised a total of $11M (USD) since Dec 1, 2022.
Add Comparison
Total Raised to Date
$11M
USD
Last Update Dec 1, 2022
Total Employees Over Time
30
As of Feb 2024
Gallant Pet Address
12130 Millenium Drive
Los Angeles,
California
90094
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts